Core Insights - Yuaneng Bio is recognized as a national-level "specialized, refined, and innovative small giant" enterprise and a high-tech company, focusing on the research and breakthroughs in deep low-temperature storage technology [1][2] - The company has applied for over 600 domestic and international patents, with more than 500 granted, including PCT patents in the US, EU, and Japan, and holds over 70 software copyrights [1] - Yuaneng Bio has developed a comprehensive ecosystem for sample management, offering an integrated solution that spans from freezing to transportation and revival [2] Group 1 - The company has successfully overcome the automation challenges of accessing samples at -196℃ ultra-low temperatures, with its P90 series fully automated storage system receiving multiple awards for its performance and innovation [1] - Yuaneng Bio's automated equipment has been successfully implemented in various projects, including those with the China CDC, Zhejiang CDC, and Suzhou CDC [2] - The company aims to create a seamless technology loop with its product line, which includes -196℃ fully automated storage systems, programmable cooling instruments, sample revival instruments, liquid nitrogen transport tanks, AGV robots, and smart library management platforms [2] Group 2 - In 2025, the company's overseas brand Orcella Instruments will launch the Orcella duo 1100S fully automated ultra-low temperature storage system, which is expected to win the "Outstanding New Product Award" from the International Society for Biological and Environmental Repositories (ISBER) [2] - Yuaneng Bio has been selected for the "Belt and Road" medical device export service platform published by the China (Shanghai) Free Trade Pilot Zone [2] - The company has developed a product matrix covering all temperature ranges and scenarios, including BSN, P, AM, IVF, PBM, and BSE series products [2]